BICO Group AB (publ) (BICO) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

BICO Q1 2025 report presentation. For the first part of the presentation, participants will be in listen-only mode. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now I will hand the conference over to the speakers, CEO Maria Force and CFO Jacob Thordenberg. Please go ahead. Hello and welcome to Baiko's earnings call where we will present the first quarter of 2025. My name is Maria Fors and I'm the president and CEO of Baiko and I will together with our CFO Jakob Thorneberg present the report. Today's agenda is divided into three sections before the Q&A. We will begin to summarize the first quarter and comment on the market development. We will then focus on the group's financial performance followed by a presentation of how our three business areas have performed during quarter one. These three sections will be in listening-only mode. After the presentation, we invite you to participate in the Q&A. The earnings call host will then be back with further instructions. I will start to summarize the first quarter of 2025 and will begin to comment on significant events and business highlights. Quarter 1 is a seasonally weak quarter for Baico. Business areas life science solutions and bioprinting showed growth thanks to commercial as well as operational excellence, primarily in selling in Sajanian, while our project business in lab automation was impacted by pure project starts and closures in combination with a high comparison quarter. Like many of our peers, we saw continued uncertain macroeconomic dynamics, for example, changes to US policy focus and reduced NIH funding, which resulted in slower academic purchases. There were also industry cutbacks in capex budgets and the potential tari...